Search Results

Business

Partek and Agilent Partner to Deliver Alissa Customers End-to-End Bioinformatics Workflow

Partek ® Incorporated announced today they have entered into an agreement with Agilent to integrate Partek ® Flow ® bioinformatics software with the Agilent Alissa Clinical Informatics Platform.

August 19, 2021

·

2 min read

Press Releases

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

November 6, 2024

·

8 min read

Press Releases

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area’s Premier Catheter Solutions Provider

November 6, 2024

·

3 min read

Press Releases

Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter Coating

August 28, 2024

·

2 min read

BioMidwest

Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Accuray Incorporated announced its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024.

February 27, 2024

·

1 min read

Press Releases

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

November 21, 2024

·

4 min read

BioMidwest

Partek Genomic Analysis Software Reaches New Citation High: Over 8,000 Peer-Reviewed Articles

Partek Incorporated announced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNAS , Cell , and Nature Medicine journals. Topics throughout their twenty-seven-year history

October 15, 2020

·

2 min read

FDA

Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program

August 12, 2024

·

16 min read

Pharm Country

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

NRx Pharmaceuticals, Inc. announced the incorporation of HOPE Therapeutics™, a biotechnology company dedicated to bringing NRX-100, which will be re-designated HTX-100, a potentially lifesaving treatment option for patients with Suicidal Depression.

February 5, 2024

·

5 min read

Business

51%: The Untapped Market

In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital Group discuss how critical it is to incorporate women into leadership positions and board rooms as a sound investment strategy.

November 21, 2024

·

1 min read

·

Lori Ellis